Biological glue is a natural adhesive generated by the interaction between fibrinogen (pre-glue) and thrombin to produce fibrin. The pre-glue is prepared from a single donor (to avoid the problems of pooled plasma) and stored as cryoprecipitate. Before being used it is thawed, dissolved in saline, and activated into an adhesive by the addition of topical thrombin. Biological glue was used prophylactically to prevent air leaks from bronchial suture lines and raw lung surfaces after pulmonary resections in six patients. In addition two new methods of using biological glue have been developed for the control of persisting air leaks. In selective intrabronchial tamponade the glue is instilled into the bronchial tree through a flexible bronchoscope, and in therapeutic pleurodesis it is instilled into the pleural cavity through a chest drainage tube. The air leaks were resolved in all cases. Seven procedures using selective intrabronchial tamponade were carried out in six patients. Four were immediately successful but three were not and required further interventions. Therapeutic pleurodesis alone was successfully carried out in one patient and as an adjunct to selective intrabronchial tamponade on two occasions. A thoracotomy was eventually needed in one of the seven patients.
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Biological glue (fibrinogen (pre-glue) plus thrombin) has been extensively used in Europe to control bleeding from cardiac and vascular suture lines' and from vascular prostheses.24 It has also been used to prevent dehiscence, leaks, and stricture formation after anastomosis of the common bile duct.'
The surface application of fibrin adhesive to control pulmonary air leaks in experimental animals was reported by Turk et al, 6 and these authors have used fibrin adhesive intraoperatively to control air leaks from pulmonary suture lines. 6 They concluded that the adhesive substantially increased the tolerance of suture lines to high airway pressure. Selective intrabronchial injection of biological glue in an attempt to achieve immediate seal of an air leak has not been reported.
The adhesive property of fibrin occurs in the final stages of the coagulation cascade ( fig  1) . The pre-glue is a fibrinogen concentrate, prepared from whole blood, plasma, or cryoprecipitate. Preparation of pre-glue from the patient's own blood would be ideal but is not practical. The commercial preparation (Tissell: Immuno Company, Vienna) is prepared from pooled plasma. This preparation is banned in the United States because of the risk of transmission of hepatitis B, the acquired immune deficiency syndrome, and other infections.
Methods

PREPARATION OF BIOLOGICAL GLUE
We have prepared our pre-glue from dry button cryoprecipitate obtained from a single donor prepared and given to us by the Red Cross. Dry button differs from the standard cryoprecipitate in that all plasma is removed before storage. The amount of fibrinogen available in our preparation was found to be fairly constant at about 60 mg per unit of cryoprecipitate. When the glue is needed, one unit of cryoprecipitate is thawed at 37°C and dissolved in 5 ml normal saline; it is ready for use in five minutes. The pre-glue is activated into adhesive by the addition of topical thrombin.
TECHNIQUE
Intraoperative prophylactic surface application offibrin glue All major air leaks must be, controlled by sutures or ligatures. The lung must be deflated and ventilation discontinued. Vesicular air leaks from resected surface are then controlled by spraying the surface with pre-glue from a syringe with a 16F plastic cannula followed by topical thrombin from another syringe. Alternatively, the pre-glue may be spread over thin sheets of oxycel cotton, which are applied to the leaking surface and then sprayed with topical thrombin. It is preferable not to restart ventilation for three minutes and a double lumen endotracheal tube is therefore advantageous. If a single lumen tube is used, ventilation can be restarted gently in one minute and fully after three minutes.
For prophylactic use over bronchial suture lines the pre-glue is sprayed on a thin sheet of oxycel cotton applied to the suture line, and this is followed by a spray of thrombin from a syringe. The use of large amounts of thrombin tends to wash away the pre-glue. The appropriate ratio of thrombin to preglue is 1:4. A pleural patch could be used instead of oxycel over the adhesive glue. It will stick without the need for sutures. into another segmental bronchus. Once the correct bronchus has been identified, 2 ml of pre-glue is injected through the catheter lumen followed by 2 ml of air. This is followed by injection of 0-5 ml (500 units) of topical thrombin, again followed by 2 ml of air, and then 1 ml of c aminocaproic acid (Amicar) and 2 ml of air. The balloon is kept inflated for three minutes, after which it is deflated and the catheter is withdrawn from the suction channel. The bronchoscope is then withdrawn for 1 cm and the area of injection visualised. The competence of the seal is finally tested by inflation at 30 cm sustained positive pressure by the anaesthetist. No air leak should occur. Some important rules must be followed to increase the chances of success: 1 The operator must ensure at the outset of the procedure that the patient is the source of the leak. The chest tube should be clamped close to the chest wall and this should eliminate the leak in the presence of continuous suction. If the leak does not stop it must be coming from the chest tube drain and not from the patient. 2 The bronchial tree must be kept dry. This may be achieved by giving atropine 0 3 mg intravenously, and repeating this if necessary. Intravenous anaesthesia is preferable as inhaled anaesthetic agents are likely to increase secretions and obscure visibility. 3 The air leak must be continuous while the chest tube is on suction. Inflation of the balloon inside a specific segmental bronchus must abolish or substantially reduce the leak.
Therapeutic pleurodesis by application of fibrin glue through the chest tube The patient is placed in the lateral supine position with the leaking side up. Ten millilitres of pre-glue is injected through the chest chest tube and the tube is clamped. The patient's position is changed every minute to allow the glue to spread over the surface of the lung. 
